NTLA
Intellia Therapeutics Inc
Biotechnology company focused on CRISPR gene editing
CUSIP: 45826J105HealthcareUS1 holder
Total Value
$115.34M
Total Shares
2.23M
Net Share Change
-240.4K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$115.34M2.23M shares
TRIM-240.4K(-9.7%)